申请人:AyuVis Research, Inc.
公开号:US11364253B2
公开(公告)日:2022-06-21
The present invention includes novel compositions and methods for treating comprising a compound with the Formula I:
where n=0-5; X═NH, O, S, CH2; Y=Phenyl, a phenyl group substituted with at least one methyl, a phenyl group substituted with at least one nitro, a phenyl group substituted with at least one nitrogen, a phenyl group substituted with at least one boron, aryl, substituted aryl, heteroaryl, four to six membered cycloalkyl, four to six membered heterocycloalkyl; R═H, C(O)R2, SO2R2; R1═H, C(O)R2, SO2R2; R2=Ethyl, methyl, isopropyl, n-propyl, t-butyl, n-butyl, NH2, NR3R4, R3, R4=Ethyl, methyl, isopropyl, n-propyl, t-butyl, n-butyl, three to six membered cycloalkyl and Z═NH, O, S, CH2 or none, wherein the amount of the compound is selected to either inhibit or activate the immune response.
本发明包括由式 I 化合物组成的新型组合物和治疗方法:
其中n=0-5;X═NH,O,S,CH2;Y=苯基,被至少一个甲基取代的苯基,被至少一个硝基取代的苯基,被至少一个氮取代的苯基,芳基,取代的芳基,杂芳基,四至六位环烷基,四至六位杂环烷基;R═H,C(O)R2,SO2R2; R1═H,C(O)R2,SO2R2;R2=Ethyl, methyl, isopropyl, n-propyl, t-butyl, n-butyl, NH2, NR3R4, R3, R4=Ethyl, methyl, isopropyl, n-propyl, t-butyl, n-butyl, three to six membered cycloalkyl and Z═NH, O, S, CH2 or none, 其中化合物的量被选择为抑制或激活免疫反应。